GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Other Current Liabilities

Tevogen Bio Holdings (FRA:G28) Other Current Liabilities : €0.39 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Other Current Liabilities?

Tevogen Bio Holdings's other current liabilities for the quarter that ended in Dec. 2024 was €0.39 Mil.

Tevogen Bio Holdings's quarterly other current liabilities declined from Jun. 2024 (€0.36 Mil) to Sep. 2024 (€0.06 Mil) but then increased from Sep. 2024 (€0.06 Mil) to Dec. 2024 (€0.39 Mil).

Tevogen Bio Holdings's annual other current liabilities increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.11 Mil) and increased from Dec. 2023 (€0.11 Mil) to Dec. 2024 (€0.39 Mil).


Tevogen Bio Holdings Other Current Liabilities Historical Data

The historical data trend for Tevogen Bio Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Other Current Liabilities Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
0.04 - 0.11 0.39

Tevogen Bio Holdings Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.21 0.36 0.06 0.39

Tevogen Bio Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Tevogen Bio Holdings Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Tevogen Bio Holdings Business Description

Traded in Other Exchanges
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

No Headlines